In addition, our observation of TFF3-mediated activation of cSRC, STAT3 and p65 (subunit of NFκB) in HER2+/ER+ breast cancer cells is consistent with published literature [31, 32, 48–50]. This evidence concerns the gene ESR1 and breast carcinoma.